These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 33830022)
1. Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor Products. Auletta JJ; Novakovich JL; Stritesky GL; Newman J; Fridy-Chesser ST; Hailperin K; Devine SM Transplant Cell Ther; 2021 Feb; 27(2):133-141. PubMed ID: 33830022 [TBL] [Abstract][Full Text] [Related]
2. Neither COVID-19, nor cryopreservation, prevented allogeneic product infusion: A report from the National Marrow Donor Program. Farhadfar N; Newman J; Novakovich J; Barten J; Ndifon ET; Oakes J; Cody M; Pham HP; Auletta JJ; Miller JP; Devine SM; Stefanski HE Front Immunol; 2022; 13():937900. PubMed ID: 36203566 [TBL] [Abstract][Full Text] [Related]
3. Demand and usage of unrelated donor products for allogeneic haematopoietic cell transplantation during the COVID-19 pandemic: A Canadian Blood Services Stem Cell Registry analysis. Allan DS; Green M; Morris G; Weiss J; Dibdin N; Mercer D; Seftel M Vox Sang; 2022 Sep; 117(9):1121-1125. PubMed ID: 35583125 [TBL] [Abstract][Full Text] [Related]
4. The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 Pandemic. Hsu JW; Farhadfar N; Murthy H; Logan BR; Bo-Subait S; Frey N; Goldstein SC; Horowitz MM; Lazarus H; Schwanke JD; Shah NN; Spellman SR; Switzer GE; Devine SM; Shaw BE; Wingard JR Transplant Cell Ther; 2021 Jun; 27(6):507-516. PubMed ID: 33865804 [TBL] [Abstract][Full Text] [Related]
5. Expanding donor options: haploidentical transplant recipients are also highly likely to have a 7/8-matched unrelated donor. Fingerson S; Maiers M; Bolon YT; Devine SM; Spellman SR Blood Adv; 2024 Feb; 8(3):758-765. PubMed ID: 38127270 [TBL] [Abstract][Full Text] [Related]
6. Urgent Time to Allogeneic Hematopoietic Cell Transplantation: A National Survey of Transplant Physicians and Unrelated Donor Search Coordinators Facilitated by the Histocompatibility Advisory Group to the National Marrow Donor Program. Pidala J; Mupfudze TG; Payton T; Barker J; Perales MA; Shaw BE; Fernández-Viña M; Burns LJ; Dehn J Biol Blood Marrow Transplant; 2019 Dec; 25(12):2501-2506. PubMed ID: 31419569 [TBL] [Abstract][Full Text] [Related]
7. Racial/ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantation. Fingrut WB; Davis E; Archer A; Brown S; Devlin S; Nhaissi M; Rapoport C; Chinapen S; Kelly A; Wells D; Scaradavou A; Gyurkocza B; Papadopoulos E; Politikos I; Shaffer BC; Barker JN Blood Adv; 2024 Jun; 8(11):2753-2764. PubMed ID: 38429097 [TBL] [Abstract][Full Text] [Related]
8. Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants. Kumar AJ; Kim S; Hemmer MT; Arora M; Spellman SR; Pidala JA; Couriel DR; Alousi AM; Aljurf MD; Cahn JY; Cairo MS; Cutler CS; Farhan S; Gergis U; Hale GA; Hashmi SK; Inamoto Y; Kamble RT; Kharfan-Dabaja MA; MacMillan ML; Marks DI; Nakasone H; Norkin M; Qayed M; Ringden O; Schouten HC; Schultz KR; Solh MM; Teshima T; Urbano-Ispizua A; Verdonck LF; Gale RP; Hamilton BK; Majhail NS; Loren AW Blood Adv; 2018 May; 2(9):1022-1031. PubMed ID: 29739773 [TBL] [Abstract][Full Text] [Related]
9. Cryopreservation of Unrelated Hematopoietic Stem Cells from a Blood and Marrow Donor Bank During the COVID-19 Pandemic: A Nationwide Survey by the Japan Marrow Donor Program. Kanda Y; Inoue M; Uchida N; Onishi Y; Kamata R; Kotaki M; Kobayashi R; Tanaka J; Fukuda T; Fujii N; Miyamura K; Mori SI; Mori Y; Morishima Y; Yabe H; Kodera Y Transplant Cell Ther; 2021 Aug; 27(8):664.e1-664.e6. PubMed ID: 33964514 [TBL] [Abstract][Full Text] [Related]
10. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia. Moore J; Nivison-Smith I; Goh K; Ma D; Bradstock K; Szer J; Durrant S; Schwarer A; Bardy P; Herrmann R; Dodds A Biol Blood Marrow Transplant; 2007 May; 13(5):601-7. PubMed ID: 17448920 [TBL] [Abstract][Full Text] [Related]
11. The National Marrow Donor Program: improving access to hematopoietic cell transplantation. Walker T; Milford E; Chell J; Maiers M; Confer D Clin Transpl; 2011; ():55-62. PubMed ID: 22755401 [TBL] [Abstract][Full Text] [Related]
12. Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR. Dehn J; Spellman S; Hurley CK; Shaw BE; Barker JN; Burns LJ; Confer DL; Eapen M; Fernandez-Vina M; Hartzman R; Maiers M; Marino SR; Mueller C; Perales MA; Rajalingam R; Pidala J Blood; 2019 Sep; 134(12):924-934. PubMed ID: 31292117 [TBL] [Abstract][Full Text] [Related]
13. Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal. Valentini CG; Chiusolo P; Bianchi M; Metafuni E; Orlando N; Giammarco S; Bacigalupo A; Sica S; Teofili L Cytotherapy; 2021 Jul; 23(7):635-640. PubMed ID: 33423867 [TBL] [Abstract][Full Text] [Related]
14. Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults. Tsai SB; Rhodes J; Liu H; Shore T; Bishop M; Cushing MM; Gergis U; Godley L; Kline J; Larson RA; Mayer S; Odenike O; Stock W; Wickrema A; van Besien K; Artz AS Biol Blood Marrow Transplant; 2018 May; 24(5):997-1004. PubMed ID: 29288821 [TBL] [Abstract][Full Text] [Related]
15. Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B-Cell acute lymphoblastic leukemia. Segal E; Martens M; Wang HL; Brazauskas R; Weisdorf D; Sandmaier BM; Khoury HJ; de Lima M; Saber W Cancer; 2017 Sep; 123(17):3346-3355. PubMed ID: 28452054 [TBL] [Abstract][Full Text] [Related]
16. The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years-a report from the EBMT acute leukemia working party. Rubio MT; Savani BN; Labopin M; Polge E; Niederwieser D; Ganser A; Schwerdtfeger R; Ehninger G; Finke J; Renate A; Craddock C; Kröger N; Hallek M; Jindra P; Mohty M; Nagler A J Hematol Oncol; 2016 Aug; 9(1):65. PubMed ID: 27488518 [TBL] [Abstract][Full Text] [Related]
17. Unrelated donor stem cell transplantation: the role of the National Marrow Donor Program. Karanes C; Confer D; Walker T; Askren A; Keller C Oncology (Williston Park); 2003 Aug; 17(8):1036-8, 1043-4, 1164-7. PubMed ID: 12966671 [TBL] [Abstract][Full Text] [Related]
18. Identification of a 10/10 matched donor for patients with an uncommon haplotype is unlikely. Olson JA; Gibbens Y; Tram K; Kempenich J; Novakovich J; Buck K; Dehn J HLA; 2017 Feb; 89(2):77-81. PubMed ID: 28102042 [TBL] [Abstract][Full Text] [Related]